A randomized phase III study of whole breast radiation versus partial breast radiation for women with breast cancer | | Loyola Medicine

UPDATE: Loyola Medicine outpatient clinics at River Forest and Elmhurst are without power today, August 12, 2020, due to storms. Patients with appointments at these locations today will receive a phone call to reschedule, or be accommodated at other locations or through a Telehealth visit. We apologize for any inconvenience.

COVID-19 (Coronavirus) Update: Learn More About Loyola Medicine Care During COVID-19.

A randomized phase III study of whole breast radiation versus partial breast radiation for women with breast cancer

Enrolled
4300
Status
Completed
Loyola Trial #
LU 108204
Title

RTOG 0413 NSABP B-39 A Randomized Phase III Study of Conventional Whole Breast Radiation vs. Partial Breast Radiation for Women with Stage 0, I or II Breast Cancer

Purpose

The purpose of this study is to see if partial breast irradiation is as good as or better than whole breast irradiation in keeping cancer from coming back in the breast.

Eligibility

Patients must have ductal carcinoma insitu or invasive adenocarcinoma of the breast. Patients must be 18 years or older. Patients must have stage 0, I or II breast cancer

Conditions and Categories
Cancer: Breast